Listar por autor "Roldán, Vanessa"
Mostrando ítems 1-4 de 4
-
Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study
Roldán Rabadán, Inmaculada; Esteve-Pastor, María Asunción; Anguita, Manuel; Muñiz, Javier; Ruiz Ortiz, Martín; Marín, Francisco; Roldán, Vanessa; Quesada, María Angustias; Camacho Siles, José; Cequier Fillat, Angel; Bertomeu-Martínez, Vicente; Martínez-Sellés, Manuel; Badimón, Lina (Elsevier, 2020-04-14)[Abstract] Background: While many risk factors for Atrial Fibrillation (AF) have been identified, there are important differences in their relative impact between sexes. The aim of our study was to investigate the influence ... -
Predictive value of the SAMe-TTR2R2 to predict quality of oral anticoagulation in atrial fibrillation: a prospective validation in the multicentre spanish observational registry FANTASIIA
Marín, Francisco; Roldán, Vanessa; Bertomeu-González, Vicente; Cequier, Ángel; Muñiz, Javier; Roldán, Inmaculada; Bertomeu-Martínez, Vicente; Badimón, Lina; Lip, Gregory; Anguita, Manuel (Oxford, 2015) -
Relationship between multimorbidity and outcomes in atrial fibrillation
Proietti, Marco; Esteve-Pastor, María Asunción; Rivera-Caravaca, José Miguel; Roldán, Vanessa; Roldán Rabadán, Inmaculada; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Badimón, Lina; Anguita, Manuel; Lip, Gregory Y.H.; Marín, Francisco (Elsevier, 2021-07-23)[Abstract] Background: Multimorbidity is common in atrial fibrillation (AF) patients. Charlson comorbidity index (CCI) is used to evaluate multimorbidity in the general population. Limited long-term data are available on ... -
Usefulness of the 2MACE score to predicts adverse cardiovascular events in patients with atrial fibrillation
Rivera-Caravaca, José Miguel; Marín, Francisco; Esteve-Pastor, María Asunción; Raña-Míguez, Paula; Anguita, Manuel; Muñiz, Javier; Cequier, Ángel; Bertomeu-Martínez, Vicente; Valdés, Mariano; Vicente, Vicente; Lip, Gregory; Roldán, Vanessa (Elsevier, 2017-09-19)[Abstract] We investigated the incidence of nonembolic adverse events in 2 cohorts of patients with atrial fibrillation (AF) and validated the 2MACE score ([metabolic syndrome, age ≥75] [doubled]; [myocardial infarction ...